- Home
- RMTI vs SER Comparison
RMTI vs SER Comparison
Compare RMTI & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMTI | SER |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | 300 | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 19.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | RMTI | SER |
|---|---|---|
| Price | $0.93 | $1.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 233.4K | 98.2K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,489,000.00 | N/A |
| Revenue This Year | N/A | $134.46 |
| Revenue Next Year | $8.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.38 | N/A |
| 52 Week Low | $0.78 | $1.47 |
| 52 Week High | $2.10 | $7.92 |
Technical Indicators
Market Signals| Indicator | RMTI | SER |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 36.19 |
| Support Level | $0.80 | $1.53 |
| Resistance Level | $1.02 | $1.86 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 33.89 | 26.92 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.